Literature DB >> 8364966

Cellular components of the immune barrier in the spinal meninges and dorsal root ganglia of the normal rat: immunohistochemical (MHC class II) and electron-microscopic observations.

J S Braun1, B Kaissling, M Le Hir, W Zenker.   

Abstract

This report deals with the distribution, morphology and specific topical relationships of bone-marrow-derived cells (free cells) in the spinal meninges and dorsal root ganglia of the normal rat. The morphology of these cells has been studied by transmission and scanning electron microscopy. Cells expressing the major histocompatibility complex (MHC) class II gene product have been recognized by immunofluorescence. At the level of the transmission electron microscope, free cells are found in all layers of the meninges. Many of them display characteristic ultrastructural features of macrophages, whereas others show a highly vacuolated cytoplasm and are endowed with many processes. These elements lack a conspicuous lysosomal system and might represent dendritic cells. Scanning electron microscopy has revealed that free cells contact the cerebrospinal fluid via abundant cytoplasmic processes that cross the cell layers of the pia mater and of the arachnoid. Cells expressing the MHC class II antigen are also found in all layers of the meninges. They are particularly abundant in the layers immediately adjacent to the subarachnoid space, in the neighbourhood of dural vessels, along the spinal roots and in the dural funnels. In addition to the meninges, strong immunoreactivity for MHC class II antigen is observed in the dorsal root ganglia. The ultrastructural and immunohistochemical findings of this study suggest the existence of a well-developed system of immunological surveillance of the subarachnoid space and of the dorsal root ganglia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8364966     DOI: 10.1007/bf00312822

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  35 in total

Review 1.  Monocyte-mediated entry of pathogens into the central nervous system.

Authors:  A E Williams; W F Blakemore
Journal:  Neuropathol Appl Neurobiol       Date:  1990-10       Impact factor: 8.090

Review 2.  Brain macrophages: evaluation of microglia and their functions.

Authors:  W E Thomas
Journal:  Brain Res Brain Res Rev       Date:  1992 Jan-Apr

3.  Macrophages related to leptomeninges and ventral nerve roots. An ultrastructural study.

Authors:  J P Fraher; R D McDougall
Journal:  J Anat       Date:  1975-12       Impact factor: 2.610

Review 4.  Macrophages and the nervous system.

Authors:  V H Perry; S Gordon
Journal:  Int Rev Cytol       Date:  1991

Review 5.  Structural and functional relationships between epidermal Langerhans cells and dendritic cells.

Authors:  N Romani; G Schuler
Journal:  Res Immunol       Date:  1989 Nov-Dec

Review 6.  [Update on lymphatic resorption of cerebrospinal fluid after review of the literature].

Authors:  J Chazal; G Vanneuville; T Scheye; M Guillot
Journal:  Bull Assoc Anat (Nancy)       Date:  1989-09

7.  [Fine structure of the choroid plexus in monkeys and apes].

Authors:  G Merker
Journal:  Z Zellforsch Mikrosk Anat       Date:  1972

8.  Electron microscopic study of the epiplexus (Kolmer) cells of the cat choroid plexus.

Authors:  S J Carpenter; L E McCarthy; H L Borison
Journal:  Z Zellforsch Mikrosk Anat       Date:  1970

Review 9.  Role of MHC gene products in immune regulation.

Authors:  B Benacerraf
Journal:  Science       Date:  1981-06-12       Impact factor: 47.728

10.  Peptides encoded by the calcitonin gene inhibit macrophage function.

Authors:  Y H Nong; R G Titus; J M Ribeiro; H G Remold
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

View more
  14 in total

1.  Leptomeningeal lipid storage patterns in Fabry disease.

Authors:  M Elleder; H Christomanou; B Kustermann-Kuhn; K Harzer
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

2.  A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction.

Authors:  Meredith Hay; Robin Polt; Michael L Heien; Todd W Vanderah; Tally M Largent-Milnes; Kathleen Rodgers; Torsten Falk; Mitchell J Bartlett; Kristian P Doyle; John P Konhilas
Journal:  J Pharmacol Exp Ther       Date:  2019-02-01       Impact factor: 4.030

3.  A novel method for modeling facial allodynia associated with migraine in awake and freely moving rats.

Authors:  Julie Wieseler; Amanda Ellis; David Sprunger; Kim Brown; Andrew McFadden; John Mahoney; Niloofar Rezvani; Steven F Maier; Linda R Watkins
Journal:  J Neurosci Methods       Date:  2009-10-29       Impact factor: 2.390

4.  Ecto-5'-nucleotidase is expressed by pericytes and fibroblasts in the rat heart.

Authors:  K Mlodzik; J Loffing; M Le Hir; B Kaissling
Journal:  Histochem Cell Biol       Date:  1995-03       Impact factor: 4.304

5.  Architecture of arachnoid trabeculae, pillars, and septa in the subarachnoid space of the human optic nerve: anatomy and clinical considerations.

Authors:  H E Killer; H R Laeng; J Flammer; P Groscurth
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

6.  Morphological indications for considerable diffuse reabsorption of cerebrospinal fluid in spinal meninges particularly in the areas of meningeal funnels. An electronmicroscopical study including tracing experiments in rats.

Authors:  W Zenker; S Bankoul; J S Braun
Journal:  Anat Embryol (Berl)       Date:  1994-03

Review 7.  Spinal interleukin-10 therapy to treat peripheral neuropathic pain.

Authors:  Erin D Milligan; Kathryn R Penzkover; Ryan G Soderquist; Melissa J Mahoney
Journal:  Neuromodulation       Date:  2012-06-01

8.  Molecular and cellular neuroinflammatory status of mouse brain after systemic lipopolysaccharide challenge: importance of CCR2/CCL2 signaling.

Authors:  Julie Cazareth; Alice Guyon; Catherine Heurteaux; Joëlle Chabry; Agnès Petit-Paitel
Journal:  J Neuroinflammation       Date:  2014-07-28       Impact factor: 8.322

9.  Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain.

Authors:  E Sloane; S Langer; B Jekich; J Mahoney; T Hughes; M Frank; W Seibert; G Huberty; B Coats; J Harrison; D Klinman; S Poole; S Maier; K Johnson; R Chavez; L R Watkins; L Leinwand; E Milligan
Journal:  Gene Ther       Date:  2009-07-02       Impact factor: 5.250

10.  Improvement of spinal non-viral IL-10 gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain.

Authors:  Ellen C Dengler; Lauren A Alberti; Brandi N Bowman; Audra A Kerwin; Jenny L Wilkerson; Daniel R Moezzi; Eugene Limanovich; James A Wallace; Erin D Milligan
Journal:  J Neuroinflammation       Date:  2014-05-21       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.